Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CC-1 |
Trade Name | |
Synonyms | CC1|CC 1 |
Drug Descriptions |
CC-1 is a bispecific antibody that targets both prostate specific membrane antigen (PSMA) and CD3, potentially resulting in antitumor activity (Cancer Res 2022;82(12_Suppl):Abstract nr CT141). |
DrugClasses | CD3 Antibody 103 PSMA Antibody 20 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CC-1 | CC-1 | 0 | 2 |
CC-1 + Tocilizumab | CC-1 Tocilizumab | 0 | 1 |